Investigating cancer disparities in Black patients through genetic and environmental analysis
Official title: SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities - University of Glasgow
Funded at University of Glasgow · NIH-11045800 · Data updated 2026-11-12
This study is looking into why Black patients, especially those with West African roots, are more likely to develop aggressive prostate, breast, and pancreatic cancers, and it aims to gather important information to help understand the reasons behind this so we can improve cancer care for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Glasgow NIH-funded |
| Lab location | 1 site (Glasgow, UNITED KINGDOM) |
| Project start | May 1, 2024 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $56,018 |
| NIH project number | 1OT2CA297465-01 |
| Project ID | NIH-11045800 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include Black patients, particularly those with a family history of prostate, breast, or pancreatic cancers.
✕Less likely to help
Patients who do not identify as Black or do not have a family history of the targeted cancers may not benefit from this research.
What this research studies
This research focuses on understanding the higher rates of aggressive prostate, breast, and pancreatic cancers in Black patients, particularly those of West African descent. By analyzing genetic, environmental, and social factors, the study aims to uncover the underlying causes of these disparities. The SAMBAI team will create a biobank and data repository to gather comprehensive data, which will help in identifying the relationships between genetics, immunology, and environmental exposures. This collaborative effort involves scientists from the US, Africa, and the UK to ensure a diverse and inclusive approach to cancer equity research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for aggressive cancers in Black patients.
How similar studies have gone: Previous research has shown success in understanding cancer disparities through genetic and environmental analyses, making this approach both relevant and promising.
Where this research is happening
-
University of Glasgow
Glasgow, United Kingdom Active
Researchers
- Principal investigator: Froeling, Fieke — University of Glasgow
- Study coordinator: Froeling, Fieke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.